Executive Summary
Across 50 SEC filings from March 16, 2026, dominant themes include a surge in M&A activity (8 deals closed, amended, or announced, e.g., Quipt going private at $3.65/share, Interactive Strength acquiring Ergatta for $8.75M+ equity), widespread executive transitions (20+ resignations, appointments, retirements across CEOs, CFOs, directors), and debt refinancings/capital raises (12 issuances totaling >$25B, often extending maturities or funding growth). Period-over-period trends where reported show mixed results: Urgent.ly Q4 revenue +4% YoY (gross margin +400bps to 26%) but FY revenue -10% YoY; Dragonfly FY revenue +15.8% YoY (OEM +33.8%) but Q4 gross margin -260bps to 18.2% and net loss widened to $(69.9M). Capital allocation leans toward buybacks (Boston Beer $25M plan), executive equity grants (Victory $79.4M, Deere $35M), and deleveraging (Armada Hoffler $562M asset sale). Biotech/pharma outliers shine with positive financings (Alto $120M, Acumen $35.75M); real estate/financials focus on restructuring. Market implications: heightened M&A signals consolidation in small-caps, leadership churn may introduce volatility but signals continuity via interim appointments, debt activity supports liquidity amid higher rates.
Tracking the trend? Catch up on the prior US Material Events SEC 8-K Filings digest from March 13, 2026.
Investment Signals(12)
- Quipt Home Medical Corp.↓(BULLISH)▲
Completed going-private acquisition at $3.65/share by Kingswood/Forager affiliates, delisting March 17; leadership views as transformative for growth
- Interactive Strength, Inc.↓(BULLISH)▲
Closed Ergatta acquisition for $3.5M cash + $5.25-9.5M preferred stock + earnouts, expanding fitness tech portfolio
- Armada Hoffler Properties (AHRT)(BULLISH)▲
Signed $562M cash sale of 11 multifamily assets to Harbor Group, +$63M financing investments; targets 5.5-6.5x net debt/EBITDA via deleveraging
- Urgent.ly Inc.↓(BULLISH)▲
Q4 revenue $33.3M +4% YoY, gross profit +23% YoY (margin +400bps to 26%), non-GAAP op income $0.2M; definitive merger with Agero announced
- Alto Neuroscience, Inc.↓(BULLISH)▲
$120M private placement at $20/share led by Commodore, pro forma cash $275M for ALTO-207 Phase 3 in 2027 (Phase 2a success)
- Acumen Pharmaceuticals, Inc.↓(BULLISH)▲
$35.75M private placement at $3.30/share led by RA Capital for EBD program (14-40x brain penetration in NHPs), IND mid-2027
- Zevra Therapeutics, Inc.↓(BULLISH)▲
Sold SDX portfolio for $50M + repaid $63M term loan, achieving debt-free status to focus on rare disease pipeline (e.g., NPC)
- Dragonfly Energy Holdings Corp.↓(BULLISH)▲
FY2025 revenue $58.6M +15.8% YoY (OEM +33.8% to $36.9M), gross profit +34.6% (margin +370bps to 26.7%); $8.9M cost savings plan
- Victory Capital Holdings, Inc.↓(BULLISH)▲
Board-approved $79.4M performance shares to 5 execs vesting on stock hurdles ($100-133/share over 7yrs), aligning with shareholders
- Deere & Co↓(BULLISH)▲
$35M one-time PSUs to top execs (May $25M) based on 5-yr SVA performance (payout 0-175%), promoting Leap Ambitions retention
- Phreesia, Inc.↓(BULLISH)▲
Refinanced $110M bridge with $275M revolver from Capital One ($92.2M drawn), lower costs post-AccessOne acquisition
- Ondas Holdings Inc.↓(BULLISH)▲
Completed Rotron Aerospace acquisition, expanding UAS/VTOL for defense/NATO; earnings call outlook March 25
Risk Flags(10)
- Air Industries Group/Exec Departure↓[HIGH RISK]▼
CEO Lou Melluzzo retires April 10 with $ severance + RSUs, no successor named amid merger restrictions
- Airbnb, Inc./Debt Refinancing↓[MEDIUM RISK]▼
Issued $2.5B notes at 4.4-5.25% (vs 0% convertibles repaid), raising future interest expense
- Urgent.ly Inc./Financial Deterioration↓[HIGH RISK]▼
FY2025 revenue -10% YoY to $129.2M, cash down to $5.3M (-63%), stockholders' deficit -$46.4M (wider), merger suspends 2026 guidance
- Dragonfly Energy/Net Losses↓[HIGH RISK]▼
FY2025 net loss $(69.9M), Q4 $(45M); Q1 2026 guidance $(4.6M) Adj EBITDA loss despite revenue growth
- Baxter International Inc./CFO Transition↓[MEDIUM RISK]▼
EVP/CFO Joel Grade departs for family, interim Anita Zielinski; search ongoing despite reiterated 2026 outlook
- Intrepid Potash, Inc./CFO Exit↓[MEDIUM RISK]▼
CFO Matthew Preston departs March 11 with $1.3M payout + equity forfeiture, interim Cris Ingold
- Helmerich & Payne/CFO Retirement↓[MEDIUM RISK]▼
SVP/CFO Kevin Vann retires June 30, new Todd Scruggs July 1 amid KCA integration
- Warner Bros. Discovery/Merger Risks↓[HIGH RISK]▼
Tax reimbursement to CEO Zaslav for excise taxes on Paramount merger payments; risks include regulatory/shareholder approval delays
- Cyngn Inc./Compensation Shift↓[MEDIUM RISK]▼
Switched to all-cash director pay ($250k/yr) + $1.64M CEO bonus due to equity impracticability, signaling liquidity strain
- Kennedy-Wilson Holdings/Merger Amendment↓[MEDIUM RISK]▼
Voting threshold changes (majority + 2/3 excluding security holders) may complicate Kona deal closure
Opportunities(10)
- Quipt Home Medical/Take-Private↓(OPPORTUNITY)◆
$3.65/share premium deal closes trading March 17; potential for undervalued assets post-delisting
- Interactive Strength/Ergatta Earnouts↓(OPPORTUNITY)◆
Milestone-based payments post-$8.75M+ deal; pro forma financials by May 27 could reveal synergies
- Armada Hoffler/Asset Sale↓(OPPORTUNITY)◆
$562M cash inflow mid-2026 reduces leverage to 5.5-6.5x, refocus on retail/office; watch $63M financing sales
- Alto Neuroscience/Financing↓(OPPORTUNITY)◆
$120M funds Phase 3 ALTO-207 (post-Phase 2a success), closes March 17; undervalued vs pipeline
- Acumen Pharmaceuticals/EBD Tech↓(OPPORTUNITY)◆
14-40x brain penetration data + $35.75M raise for IND mid-2027; JCR collab since 2025
- Zevra Therapeutics/Debt-Free Pivot↓(OPPORTUNITY)◆
$50M SDX sale + loan repayment enables rare disease focus (NPC); post-10K filed March 9
- MSC Income Fund/Notes Offering↓(OPPORTUNITY)◆
$150M 6.34% notes closed March 13 for investments; targets lower middle-market growth
- Waste Connections/Debt Issuance↓(OPPORTUNITY)◆
$600M 4.8% notes due 2036 at favorable terms, no sub guarantees; strong covenant package
- Ondas Holdings/Rotron Acquisition↓(OPPORTUNITY)◆
UK UAS expansion for defense; earnings March 25 to provide outlook
- Victory Capital/Exec Incentives↓(OPPORTUNITY)◆
$79.4M PSUs on 50-100% appreciation hurdles over 7yrs; signals mgmt conviction
Sector Themes(6)
- M&A Consolidation Wave(THEME)◆
10/50 filings (20%) detail M&A (Quipt private, Interactive/Ergatta, Ondas/Rotron, Armada sales, Urgent.ly/Agero, Zevra sale); implies small-cap/private equity pressure, alpha in targets/premiums
- Executive Churn High(THEME)◆
25/50 (50%) involve C-level/director changes (12 resignations/retirements, 10 appointments); neutral sentiment but interim roles (Baxter, Intrepid) suggest continuity, watch for performance impacts
- Debt Refinancing Surge(THEME)◆
12 issuances/refinancings totaling >$25B (Airbnb $2.5B, Waste $600M, MSC $150M, Phreesia $275M rev); extends maturities (e.g., Duke to 2031), mixed rates but enhances liquidity amid high rates
- Biotech Financing Strength(THEME)◆
4 positive raises (Alto $120M, Acumen $35.75M, etc.) with strong data (14-40x penetration, Phase success); contrasts broader market, pipeline catalysts 2026-27
- Capital Return via Equity Grants(THEME)◆
$150M+ in performance shares (Victory $79.4M, Deere $35M); ties pay to hurdles/SVA, bullish alignment vs cash dividends
- Mixed Financial Trends(THEME)◆
Reported metrics show revenue growth (Urgent.ly Q4 +4%, Dragonfly FY +15.8%) but margin volatility (-260bps Q4 Dragonfly) + losses widening; cost cuts ($8.9M Dragonfly) signal turnarounds
Watch List(8)
No CEO named post-Melluzzo April 10 retirement; monitor merger with Tenax Aerospace [WATCH: April 10, 2026]
Agero acquisition suspends guidance; track Q4 metrics in full earnings post-merger [WATCH: Ongoing 2026]
$(4.6M) Adj EBITDA loss guided; cost savings $8.9M rollout [WATCH: Q1 2026 results]
$120M deal March 17; Phase 2b H1 2026 start [WATCH: March 17, 2026]
$562M multifamily sale mid-2026 + $63M investments [WATCH: Mid-2026]
Rotron acquisition outlook, defense synergies [WATCH: March 25, 2026]
- AIG/Annual Meeting👁
Director Dunne not re-electing May 13; board refresh [WATCH: May 13, 2026]
Tax deal for Zaslav, regulatory/shareholder risks [WATCH: 2026 closure]
Filing Analyses(50)
16-03-2026
Quipt Home Medical Corp. completed its previously announced plan of arrangement on March 16, 2026, whereby 1567208 B.C. Ltd. (with funding from affiliates of Kingswood Capital Management and Forager Capital Management) acquired all outstanding shares for $3.65 USD per share, taking the company private. Shares will cease trading and be delisted from NASDAQ and TSX at close of business on March 17, 2026, with the company intending to terminate public reporting obligations in the U.S. and Canada. Leadership highlighted the transaction as transformative for long-term growth, though it ends public trading and reporting.
- ·Arrangement Agreement dated December 14, 2025
- ·Management information circular and proxy statement dated January 23, 2026
- ·All Quipt Options and RSUs cancelled in exchange for cash payments equal to ($3.65 minus exercise price) per underlying share (net of withholdings)
- ·Legal advisors: DLA Piper (Company), McDermott Will & Schulte LLP and Fasken Martineau DuMoulin LLP (Kingswood, Forager, Purchaser)
- ·Financial advisors: Truist Securities and Evans & Evans (Company and Strategic Transactions Committee), UBS Investment Bank (Kingswood)
16-03-2026
On March 11, 2026, Lou Melluzzo resigned as Chief Executive Officer and President of Air Industries Group and its subsidiaries to retire, with the resignation described as voluntary and without any disagreements on company matters. Under the Separation and Release Agreement dated March 13, 2026, Melluzzo will receive continued salary and benefits until the Separation Date of April 10, 2026, plus two months' base salary severance, net settlement of 34,123 RSU shares vesting April 1, 2026, 12,159 RSU shares from a February 2026 grant, and retention of options for 128,000 shares, subject to merger restrictions with Tenax Aerospace Acquisition LLC. No successor CEO appointment is mentioned.
- ·Executive restricted from soliciting employees, customers/suppliers/contractors, or engaging in competitive activities (e.g., Competitive Products) for 12 months post-Effective Date.
- ·Mutual 5-year non-disparagement clause between Executive and Company officers/directors.
- ·21-day Consideration Period and 7-day Release Revocation Period for the Agreement.
- ·Separation Date: April 10, 2026; Executive not to appear at offices from March 13, 2026, but available for transition support until then.
16-03-2026
Interactive Strength Inc. (TRNR) completed its acquisition of Ergatta, Inc. on March 11, 2026, through a merger making Ergatta a wholly owned subsidiary, with total consideration including $3.5M cash ($1.75M paid upfront, subject to adjustments, and $1.75M deferred via a senior secured promissory note maturing April 30, 2027) and Series D1 Convertible Preferred Stock valued between $5.25M and $9.5M. Equity incentives to Ergatta's senior management included Series D2 Preferred Stock (up to $2M) and Series D3 Preferred Stock (up to $1M). Ergatta stockholders may receive additional milestone-based earnouts; required financial statements and pro forma information will be filed by amendment no later than May 27, 2026.
- ·Merger Agreement originally dated February 18, 2026.
- ·Series D Preferred Stock issued exempt from registration under Section 4(a)(2) of the Securities Act of 1933.
- ·Financial statements and pro forma information for Ergatta to be filed by amendment no later than May 27, 2026 (71 days after original due date).
16-03-2026
Airbnb, Inc. closed a $2.5B public offering of senior notes on March 16, 2026, comprising $850M 4.400% notes due 2029, $850M 4.650% notes due 2031, and $800M 5.250% notes due 2036, under an underwriting agreement dated March 12, 2026, with BofA Securities, Inc., Goldman Sachs & Co. LLC, and Morgan Stanley & Co. LLC as representatives. Net proceeds were used to repay $2.0B of maturing 0% convertible senior notes due March 2026, successfully refinancing short-term obligations with longer maturities to 2029-2036. However, the new notes carry higher interest rates of 4.4%-5.25% compared to 0%, increasing the company's future interest expense.
- ·Notes redeemable prior to Par Call Dates at Treasury Rate plus 10 bps (2029), 15 bps (2031), or 20 bps (2036).
- ·Par Call Dates: February 16, 2029 (2029 Notes), February 16, 2031 (2031 Notes), December 16, 2035 (2036 Notes).
- ·Change of Control Triggering Event allows holders to require repurchase at 101% of principal.
- ·Indenture covenants limit liens, sale-leasebacks, and mergers; events of default include payment defaults and acceleration of other indebtedness over $250M.
16-03-2026
On March 13, 2026, the Board of Victory Capital Holdings, Inc. approved a one-time grant of performance-based restricted stock awards (Performance Shares) to five key executives under the 2018 Equity Plan, totaling approximately $79.4M in grant value based on the March 13 closing stock price. The awards vest in 25% tranches upon achieving stock price hurdles of $100.01 (50% appreciation), $110.01 (65%), $120.01 (80%), and $133.34 (100%) over a seven-year measurement period starting March 15, 2026, with a one-year post-vesting hold requirement. This grant aims to align executive interests with stockholders, promote retention, and reduce future time-vested grants starting 2026.
- ·Measurement period: seven years commencing March 15, 2026; hurdles achieved if average closing price meets target for five consecutive trading days.
- ·Performance Shares forfeit if hurdles not met by end of measurement period.
- ·No acceleration or continued vesting upon termination except for David C. Brown per employment agreement.
- ·Future annual time-vested grants to recipients expected to decrease starting 2026.
16-03-2026
CoStar Group, Inc. (NASDAQ: CSGP) appointed Nana Banerjee as a new independent director to its Board of Directors, effective immediately on March 16, 2026, expanding the board to nine members with eight independent directors. Banerjee brings over two decades of experience in leading technology, data, AI, and analytics businesses from roles including CEO of Pelmorex Corp., Senior Managing Director at Cerberus Capital Management, and CEO of McGraw-Hill. The appointment supports the company's long-term growth strategy in AI and advanced analytics, as stated by CEO Andy Florance and Board Chair Louise Sams.
- ·CoStar Group’s websites attracted over 139 million average monthly unique visitors in the fourth quarter of 2025.
- ·Founded in 1986 and headquartered in Arlington, Virginia.
16-03-2026
Kennedy-Wilson Holdings, Inc. executed an Amendment dated March 15, 2026, to its Agreement and Plan of Merger originally dated February 16, 2026, with Kona Bidco, LLC (Parent) and Kona Merger Subsidiary, Inc. (Merger Sub). The amendment restates Section 4.05 to require (a) a majority vote of Company Voting Stock (Common Stock, Series A Preferred on as-converted basis, Series B and C Preferred based on warrants) voting as a single class, and (b) a two-thirds vote excluding shares owned by Security Holders and affiliates; it also restates Section 4.06 to confirm no other anti-takeover laws apply except possibly DGCL Section 203. The changes were approved by the Special Committee and do not alter other terms of the Agreement.
- ·Amendment effective as of March 15, 2026; original Agreement dated February 16, 2026.
- ·Special Committee approved the Amendment.
- ·References to Agreement date remain February 16, 2026.
16-03-2026
James Dunne III notified the Board of Directors of American International Group, Inc. (AIG) on March 10, 2026, that he will not stand for re-election at the 2026 Annual Meeting of Shareholders scheduled for May 13, 2026. Mr. Dunne cited no disagreement with the Company's operations, policies, or practices and will continue serving on the Board and the Compensation and Management Resources Committee until the meeting. The 8-K filing was submitted on March 16, 2026.
- ·Date of earliest event reported: March 10, 2026
- ·AIG's principal executive offices: 1271 Avenue of the Americas, New York, New York 10020
- ·AIG common stock trades on NYSE under symbol AIG, par value $2.50 per share
16-03-2026
AH Realty Trust (NYSE: AHRT), formerly Armada Hoffler, entered a binding agreement to sell 11 multifamily properties to an affiliate of Harbor Group International for $562M in cash, with a $15M nonrefundable deposit, expected to close mid-2026 subject to customary conditions. Proceeds will fund debt reduction toward a 5.5x-6.5x net debt to adjusted EBITDA target, simplifying the platform and focusing on retail/office. The company is also in advanced negotiations to sell two real estate financing investments for ~$63M, though no assurances of closing.
- ·Retains Smith’s Landing multifamily asset; intends to market Everly and Solis Gainesville for sale.
- ·Transaction formalizes February 16, 2026 letter of intent.
- ·Rebranded as AH Realty Trust effective March 2, 2026 (NYSE: AHRT).
- ·Restructuring also includes divesting construction and real estate financing businesses; targeting retail acquisitions.
16-03-2026
Urgently reported Q4 2025 revenue of $33.3M, up 4% YoY, gross profit of $8.7M (+23% YoY) with margin expansion to 26% (vs 22%), GAAP operating loss of $2.5M (improved 46% YoY), and non-GAAP operating income of $0.2M. However, full-year 2025 revenue declined 10% YoY to $129.2M despite gross profit growth of 4% and significant operating expense reductions (GAAP -29%, non-GAAP -32%). The company announced a definitive merger agreement to be acquired by Agero, Inc., leading to cancellation of the earnings call and suspension of 2026 guidance.
- ·Q4 consumer satisfaction score of 4.7/5; FY score of 4.6/5.
- ·Cash and equivalents declined to $5.3M as of Dec 31, 2025 from $14.2M prior year.
- ·Total liabilities increased to $90.1M from $85.7M; stockholders' deficit widened to $46.4M from $31.7M.
- ·Q4 net loss of $4.2M improved from $8.7M YoY; FY net loss $20.4M improved from $44.0M.
- ·Revolving credit facility $12.7M as current liability Dec 31, 2025.
16-03-2026
KORU Medical Systems, Inc. announced the retirement of CEO Linda Tharby effective June 30, 2026, with Adam Kalbermatten appointed as President effective March 15, 2026, and succeeding as CEO on July 1, 2026. Tharby will serve as a non-executive advisor and Board member through December 31, 2026, receiving continued base salary at 50% rate during the advisory period and specific equity vesting, while some PSUs were previously cancelled. Kalbermatten's compensation includes base salary increasing to $525,000 and significant LTI awards totaling up to $1.25M annually.
- ·Tharby ineligible for bonus/incentives post-June 30, 2026; remaining unvested awards forfeited after Dec 31, 2026 except specified tranches.
- ·Kalbermatten eligible for severance including 12 months salary continuation and 100% bonus target upon qualifying termination.
- ·Tharby non-compete and restrictive covenants remain in effect; no equity sales during advisory period without Board approval.
16-03-2026
MSC Income Fund, Inc. (NYSE: MSIF) announced the closing of a $150.0 million private investment grade notes offering on March 13, 2026. The unsecured notes bear a fixed interest rate of 6.34% per year, payable semiannually, and mature on May 31, 2029, with optional redemption at par plus accrued interest and a potential make-whole premium. Net proceeds will initially repay a portion of outstanding debt under its revolving credit facility, with re-borrowing to fund investments, operating expenses, and general corporate purposes.
- ·Notes are unsecured and may be redeemed in whole or in part at MSC Income’s option.
- ·Fund's private loan portfolio companies generally have annual revenues between $25M and $500M.
- ·Fund's lower middle market portfolio companies generally have annual revenues between $10M and $150M.
- ·Notes not registered under Securities Act of 1933 and subject to state securities laws exemptions.
16-03-2026
Alto Neuroscience, Inc. (ANRO) announced a $120M private placement financing led by Commodore Capital with participation from investors including Perceptive Advisors and Venrock Healthcare Capital Partners, selling 2.9M shares at $20.00 each and 3.1M pre-funded warrants. Proceeds will fund ALTO-207 development through a planned Phase 3 trial in treatment-resistant depression and potential NDA submission, with pro forma cash of $275M as of February 28, 2026. The deal is expected to close March 17, 2026.
- ·Phase 2b study of ALTO-207 expected to initiate in first half of 2026; Phase 3 in early 2027.
- ·ALTO-207 Phase 2a trial met primary and secondary endpoints, well-tolerated with adverse event rate similar to placebo.
16-03-2026
Acumen Pharmaceuticals announced a $35.75M private placement of common stock at $3.30 per share, led by RA Capital Management with participation from ADAR1 Capital Management, Sands Capital, and others, expected to close on or about March 16, 2026, to fund the Enhanced Brain Delivery (EBD) program targeting an IND submission in mid-2027. Preclinical data from the EBD program, utilizing JCR Pharmaceuticals' J-Brain Cargo® technology, demonstrated development candidates achieving 14-40x higher brain penetration in non-human primates compared to native antibodies, low anemia risk, and suitability for subcutaneous administration. No negative or flat performance metrics were reported.
- ·Private placement price: $3.30 per share
- ·EBD candidates showed 14-40x higher brain levels in NHPs at 24 hours vs. native antibodies
- ·EBD collaboration with JCR announced in July 2025
- ·Ongoing Phase 2 trial of sabirnetug in early symptomatic Alzheimer’s disease
16-03-2026
Constantine S. Mihas resigned as a Class I director of Sotera Health Company effective March 16, 2026, due to a reduction in the number of directors certain stockholders are entitled to designate, with no disagreements on company matters. The Board appointed Kenneth D. Krause, Executive Vice President and Chief Financial Officer of Rollins, Inc., as a replacement Class I director effective the same date; he will serve on the Audit and Litigation Committees and is deemed independent under Nasdaq rules. Mr. Krause brings extensive finance leadership experience from Rollins (since September 2022) and MSA Safety (2006-2022).
- ·Resignation notified on March 12, 2026; appointment on March 15, 2026.
- ·Mr. Krause previously served as SVP, CFO, Chief Strategy Officer, and Treasurer at MSA Safety from December 2015 to September 2022.
- ·Mr. Krause holds a BS in Business Administration (Accounting) from Slippery Rock University, MBA from University of Pittsburgh Katz Graduate School, and is a CPA (inactive) in Pennsylvania.
- ·Compensation per non-employee director policy in April 10, 2025 Proxy Statement: annual cash retainer and RSUs.
- ·Customary indemnification agreement; no arrangements or reportable transactions under Item 404(a).
16-03-2026
SiriusPoint Ltd. announced a business restructuring into four divisions: Global P&C Programs (combining North America and International Programs, led by Patrick Charles), Global Reinsurance, Global Accident & Health, and London Market Specialty (including Syndicate 1945 and led by David Govrin). As part of the changes, Rob Gibbs is leaving the company. CEO Scott Egan highlighted the restructuring as building on significant progress, including financial momentum at the end of 2025, to capitalize on growth opportunities.
- ·Financial strength ratings: A from Fitch, A- from AM Best and S&P, A3 from Moody’s.
- ·Bermuda-headquartered with offices in New York, London, Stockholm and other locations.
- ·Filing date: March 16, 2026
16-03-2026
Zevra Therapeutics sold its entire serdexmethylphenidate (SDX) portfolio, including AZSTARYS® and KP1077, to Commave Therapeutics for $50 million, simultaneously resolving a 2024 lawsuit in Delaware Chancery Court. The company fully repaid its $63 million term loan prior to the agreement, achieving a debt-free balance sheet and enhanced financial flexibility. This allows Zevra to focus on its rare disease pipeline, including therapies for Niemann-Pick disease type C (NPC).
- ·2019 license agreement granted Commave exclusive license to certain SDX products.
- ·Litigation initiated by Commave against Zevra in Delaware Chancery Court in 2024.
- ·Annual Report on Form 10-K for year ended December 31, 2025, filed March 9, 2026.
16-03-2026
On March 11, 2026, James Peters, Executive Vice President of Whirlpool Corporation, announced his resignation from the company effective March 30, 2026. This follows his previously reported step-down from the roles of Chief Financial Officer and President, Whirlpool Asia, effective December 31, 2025, as part of the company's ongoing talent planning process. No successor has been named in the filing.
- ·Filing signed by Bridget K. Quinn on March 16, 2026
- ·Company directs investors to monitor the 'Investors' section of whirlpoolcorp.com for material disclosures under Regulation FD
16-03-2026
Flowserve Corporation (NYSE: FLS) elected Brian Savoy to its Board of Directors effective March 16, 2026, appointing him to the Audit Committee and Technology, Innovation and Risk Committee. Savoy, current CFO and Executive Vice President at Duke Energy, brings extensive power industry leadership, including nuclear expertise, to support Flowserve's growth in power markets and the Flowserve Business System. Company leadership expressed enthusiasm for his financial, transformation, and strategy experience.
- ·Brian Savoy serves as board member and audit committee chair for the Electric Power Research Institute.
- ·Brian Savoy holds a Bachelor of Business Administration in accounting from Lamar University and is a certified public accountant.
16-03-2026
Baxter International Inc. announced the departure of EVP and CFO Joel Grade to prioritize family matters, with him continuing in an advisory role until April 30, 2026. Anita Zielinski, who joined in 2025 as SVP, Chief Accounting Officer and Controller, has been appointed interim CFO effective immediately while the company searches for a permanent replacement. Baxter is reiterating its full-year 2026 financial outlook originally provided on February 12, 2026, signaling continuity amid the transition.
- ·Anita Zielinski previously served as SVP and CFO, U.S. Foodservice Operations at Sysco Corporation and spent over 20 years at Ernst & Young LLP as an audit partner.
- ·Media Contact: Stacey Eisen, (224) 948-5353; Investor Contact: Kevin Moran, (224) 948-3085
16-03-2026
Seer, Inc. entered into Amendment No. 1 to its Tax Benefit Preservation Plan on March 13, 2026, clarifying the definition of 'Beneficial Ownership' to address challenges raised in a stockholder lawsuit filed on March 3, 2026, in the Delaware Court of Chancery (Taylor v. Farokhzad). The amendment moots the litigation, leading to its dismissal, with Seer agreeing to pay plaintiff's counsel a $250,000 mootness fee solely to avoid litigation costs. This constitutes a material modification to the rights of security holders.
- ·Original Tax Benefit Preservation Plan dated February 26, 2026.
- ·Amended complaint filed March 3, 2026, in Taylor v. Farokhzad, C.A. No. 2025-1232-PAF, Delaware Court of Chancery.
- ·Amendment clarifies interaction of 'Beneficial Ownership' with Treasury Regulation § 1.382-3(a)(1).
16-03-2026
The Boston Beer Company, Inc. (SAM) announced that Director Michael Spillane will not stand for re-election and retire from the Board effective at the conclusion of the 2026 Annual Meeting of Stockholders, with the decision not due to any disagreements on operations, policies, or practices. On March 10, 2026, the company entered into a 10b5-1 plan to repurchase up to $25 million of its Class A Common Stock, with repurchases commencing March 30, 2026, and ending June 26, 2026.
- ·Spillane informed Chairman on March 13, 2026.
- ·Filing signed on March 16, 2026.
16-03-2026
On March 11, 2026, the Board of Directors of BILL Holdings, Inc. appointed Rohini Jain, the company's Chief Financial Officer, to also serve as principal accounting officer under the Securities Exchange Act of 1934. No additional compensation will be provided for this role. Biographical information on Ms. Jain is incorporated from the company's Form 8-K filed on June 2, 2025.
- ·Principal executive offices: 6220 America Center Drive, Suite 100, San Jose, California 95002
- ·Common Stock ($0.00001 par value) trades as BILL on NYSE
16-03-2026
Phreesia, Inc. refinanced its $110 million bridge loan—originally used for the AccessOne Acquisition—with a new $275 million senior secured revolving credit facility from Capital One, borrowing $92.2 million at closing to repay the remaining balance after a $20 million repayment during the fiscal quarter ended January 31, 2026. The new facility replaces a prior $50 million asset-based revolver and is expected to reduce borrowing costs while enhancing financial flexibility, according to CEO Chaim Indig. No penalties were incurred in terminating the bridge loan or prior facility.
- ·Bridge loan was a 364-day $110M secured term loan dated November 12, 2025.
- ·Phreesia founded in 2005.
- ·New Credit Facility available for working capital, capital expenditures, permitted acquisitions, and general corporate purposes.
16-03-2026
Gevo, Inc. disclosed that Dr. Angelo Amorelli informed the Board on March 11, 2026, that he will not stand for re-election at the 2026 Annual Meeting of Stockholders for personal reasons, with no disagreements on operations, policies, or practices. He will continue serving until the expiration of his term at the Annual Meeting. The company expressed thanks for his contributions.
- ·Filing date: March 16, 2026
- ·Date of earliest event: March 11, 2026
16-03-2026
On March 12, 2026, Kei Tung Yeung resigned as a director of Rising Dragon Acquisition Corp., a blank check company, with no disagreement cited. Xiaomin Pang, age 53 and a Chinese Certified Public Accountant with over 25 years of experience in accounting, auditing, and financial management, was appointed to succeed him. The company highlighted Pang's expertise in audit, financial controls, and governance to strengthen reporting and risk management; no family relationships or material transactions involving Pang were disclosed.
- ·Company incorporated in Cayman Islands, principal address: No. 604, Yixing Road, Wanbolin District, Taiyuan City, Shanxi Province, China.
- ·Securities: Units (RDACU), Ordinary Shares (RDAC), Rights (RDACR) listed on Nasdaq.
- ·Emerging growth company status confirmed.
- ·Mr. Pang has no family relationships with executives/directors and no material transactions in past two years.
16-03-2026
Everest Group, Ltd. entered into a Separation, Transition Services and General Release Agreement dated March 13, 2026, with its former Executive Vice President and General Counsel, Ricardo Anzaldua, in connection with a previously announced General Counsel transition. The Company agreed to pay $7.25 million in recognition of his service, accrued payments, and for providing advisory services during an extended transition period of up to nine months. The agreement also includes a waiver of Mr. Anzaldua's non-compete covenant after advisory services end and an extension of his non-solicit covenant for an additional six months.
- ·Agreement filed in connection with previously announced General Counsel transition.
- ·Forfeiture of previously granted equity awards by Mr. Anzaldua.
- ·Full release of all contractual entitlements, claims, rights, and other undertakings.
- ·Full text of the Agreement to be filed as an exhibit to a subsequent Form 10-Q.
16-03-2026
On March 16, 2026, Duke Energy Corporation and subsidiaries including Duke Energy Carolinas, LLC, Duke Energy Progress, LLC, Duke Energy Florida, LLC, Duke Energy Indiana, LLC, Duke Energy Ohio, Inc., Duke Energy Kentucky, Inc., and Piedmont Natural Gas Company, Inc., entered into Amendment No. 3 to their Amended and Restated Credit Agreement originally dated March 18, 2022, with Wells Fargo Bank, National Association as Administrative Agent. The amendment extends the credit facility's termination date from March 16, 2030, to March 16, 2031, providing extended liquidity access. No financial terms such as facility size or costs were disclosed in the filing.
- ·Amendment filed as Exhibit 10.1
- ·Multiple co-registrants including CIKs 0000030371, 0000017797, 0000037637, 0000020290, 0000081020, 0000078460
16-03-2026
On March 15, 2026, the Board of Directors of Empire State Realty Trust, Inc. appointed Jean Sutherland as Chief Accounting Officer and principal accounting officer for both the Company and Empire State Realty OP, L.P., effective March 16, 2026. Stephen V. Horn will continue as Chief Financial Officer while transitioning his Chief Accounting Officer duties to Ms. Sutherland, to whom she will report. The filing notes no arrangements, family relationships, or material interests related to the appointment.
- ·Ms. Sutherland, age 38, has served as Vice President, Financial Reporting and Accounting Policy since June 17, 2024.
- ·Prior to the Company, Ms. Sutherland spent over seven years at WeWork and over five years at Ernst & Young LLP.
- ·The Company expects to enter into a standard indemnification agreement with Ms. Sutherland.
16-03-2026
Veracyte, Inc. (VCYT) announced the appointment of Dr. Kevin Haas as Chief Development and Technology Officer, effective March 24, 2026, following board approval on March 13, 2026. Dr. Haas, formerly Chief Technology Officer at Myriad Genetics, Inc. (MYGN) since February 2021, brings extensive experience in genetic testing and bioinformatics. Compensation includes an initial annual base salary of $500,000, target bonus opportunity of 55% of eligible earnings (prorated for 2026), and equity awards with $3M total target value vesting over four years.
- ·Appointment announced March 16, 2026; offer letter dated March 13, 2026.
- ·Dr. Haas previously held roles as SVP Technology, SVP Engineering, VP and Senior Director of Bioinformatics at Myriad.
- ·Equity awards under 2023 Equity Incentive Plan; standard indemnification agreement to be executed.
- ·No family relationships, arrangements, or material transactions under Item 404(a) of Regulation S-K.
16-03-2026
Waste Connections, Inc. completed an underwritten public offering of $600M aggregate principal amount of 4.800% Senior Notes due 2036 on March 16, 2026, under an existing indenture supplemented by the Eleventh Supplemental Indenture. The notes are senior unsecured obligations, pay interest semi-annually starting July 15, 2026, mature on July 15, 2036, and include redemption options prior to April 15, 2036 at a make-whole price or par thereafter, with a change of control repurchase at 101% of principal. No subsidiary guarantees or negative performance metrics were reported in connection with the issuance.
- ·Notes rank equally with other unsubordinated debt and senior to future subordinated debt; not guaranteed by subsidiaries.
- ·Customary covenants include limitations on liens, sale-leaseback transactions, and mergers/sales of substantially all assets.
- ·Events of default include non-payment of interest (30 days), principal at maturity, covenant breaches (60 days), and bankruptcy events.
16-03-2026
Honeywell Aerospace Inc. entered into a Registration Rights Agreement dated March 16, 2026, with representatives Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC, covering $16B aggregate principal amount of Senior Notes issued pursuant to a Purchase Agreement dated March 10, 2026. This includes $10B in new money notes (various tranches maturing 2028-2036) issued by the Company and $6B in exchange notes (maturing 2046-2066) sold by selling securityholders, all guaranteed by Honeywell International Inc. The agreement mandates a Registered Exchange Offer to be completed no later than 365 days after the Honeywell Aerospace Spin-Off or related successor assumption.
- ·Registered Exchange Offer must be completed no later than 60 days after Exchange Offer Registration Statement effectiveness, but no later than 365 days after Honeywell Aerospace Spin-Off consummation or successor assumption under Indenture Article 10.
- ·Exchange Offer open for not less than 20 Business Days.
- ·Securities issued under Base Indenture and First Supplemental Indenture, both dated March 16, 2026.
16-03-2026
ACRC Lender LLC, a subsidiary of Ares Commercial Real Estate Corp (ACRE), entered into an amendment to its secured revolving funding facility with City National Bank on March 10, 2026, extending the maturity date to December 31, 2026, in exchange for a renewal fee. The amendment qualifies as a material definitive agreement and creates a direct financial obligation. No specific details on the facility size, fee amount, or other terms were disclosed.
16-03-2026
PENN Entertainment, Inc. closed a private offering of $600 million aggregate principal amount of 6.750% senior notes due April 1, 2031, issued at par under an indenture with Computershare Trust Company, National Association. Proceeds will repay outstanding amounts under its revolving credit facility and support general corporate purposes. The unsecured notes are effectively subordinated to secured indebtedness, including under the Credit Agreement, and include covenants restricting debt incurrence, dividends, investments, liens, and other activities.
- ·Interest payable semi-annually in arrears on April 1 and October 1, commencing October 1, 2026.
- ·Optional redemption prior to April 1, 2028 at make-whole premium or 106.750% of principal with equity offering proceeds (if >=60% notes remain outstanding).
- ·Notes subject to covenants that cease upon investment grade ratings from Moody’s and S&P.
- ·Customary events of default with grace periods.
16-03-2026
Aptiv PLC announced on March 13, 2026, that Javed Khan is resigning as Executive Vice President and President, Intelligent Systems, effective March 30, 2026, to become CEO of an unnamed software and AI company. Post-departure, Mr. Khan will join Aptiv's Technology Advisory Committee. Kevin Clark, Chair and Chief Executive Officer, will assume the role of interim President, Intelligent Systems until a successor is named.
16-03-2026
The Western Union Company (NYSE: WU) appointed Milind Pant, age 55 and a global business leader with experience at Amway, Pizza Hut International, Yum! China, and Unilever, as an independent director to its Board, effective March 13, 2026. Jeff Joerres, Chair of the Board, highlighted Pant's expertise in digital transformation and global consumer markets to support Western Union's strategic priorities. No declines or flat metrics reported in this governance update.
- ·Milind Pant led a six-year transformation at Amway as its first non-family CEO.
- ·Mr. Pant spent 15 years with Unilever across India, Africa, the Middle East, and Turkey.
- ·Mr. Pant has led companies in five countries across three continents.
- ·Mr. Pant will serve on the Audit and Compliance Committees of the Board.
16-03-2026
Warner Bros. Discovery, Inc. (WBD) entered into a Tax Reimbursement Agreement with CEO David Zaslav on March 10, 2026, to reimburse potential excise taxes on merger-related payments from the pending merger with Paramount Skydance Corporation (PSKY), with the actual amount unknown and potentially zero if the merger closes in 2027. The agreement was approved by the Compensation Committee, citing relative disadvantages compared to a prior Netflix transaction and post-merger cost bearing by the surviving entity. Extensive risks to the merger completion are highlighted, including regulatory approvals, shareholder vote, and market impacts.
- ·Agreement terminates if Merger Agreement ends.
- ·Merger reported in prior 8-K on February 27, 2026.
16-03-2026
On March 11, 2026, Cyngn Inc.'s Board approved a switch to all-cash compensation for independent non-employee directors effective Q1 2026 at $250,000 annually ($62,500 quarterly) per director, replacing prior cash and equity components until equity grants are practicable again. The Board also approved one-time $200,000 cash payments to directors Karen Macleod and James McDonnell for FY 2025 in lieu of equity awards. Additionally, the Compensation Committee approved a $1.64M cash bonus for CEO Lior Tal for FY 2025, comprising $0.64M regular and $1M special bonuses.
- ·Compensation changes approved unanimously by the Board upon Compensation Committee recommendation.
- ·All-cash director structure remains until Board determines equity-based compensation practicable again.
- ·Filing signed by Natalie Russell, CFO, on March 16, 2026.
16-03-2026
Sono Group N.V. (SSM) disclosed in an 8-K filing on March 16, 2026, entry into a 2002 ISDA Master Agreement with BLOCKCHAIN.COM (BVI) II LTD dated March 10, 2026. The standard agreement governs potential swaps and derivatives transactions (each a 'Transaction') between the parties, including netting, tax withholding, representations, and events of default. No specific transactions, amounts, or financial obligations are detailed in the exhibit.
- ·Filing Items: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 8.01, 9.01
- ·Agreement includes standard ISDA provisions on payment netting, tax gross-up, basic representations, and events of default
16-03-2026
Dragonfly Energy reported preliminary FY 2025 revenue growth of 15.8% YoY to $58.6M, driven by 33.8% increase in OEM sales to $36.9M, while DTC sales declined 8.5% to $20.7M and Q4 gross margin fell to 18.2% from 20.8%. Net loss widened significantly to $(69.9)M for FY and $(45.0)M for Q4 amid higher operating expenses and one-time items. The company announced strategic cost realignments targeting $8.9M in annualized savings, including 20% payroll cuts and facility consolidation, with Q1 2026 guidance of $9.5M revenue and $(4.6)M Adjusted EBITDA loss.
- ·Q1 2026 Adjusted EBITDA guidance of $(4.6)M loss.
- ·Licensing fees flat at $0.25M in Q4 2025 YoY.
- ·FY 2025 gross profit increased 34.6% to $15.6M with margin expansion of 370 bps to 26.7%.
- ·Targets positive Adjusted EBITDA at $70M annual revenue run rate.
- ·Executive compensation reductions effective April 1, 2026.
16-03-2026
Corebridge Financial, Inc. disclosed that Minoru Kimura, a director designated by Nippon Life Insurance Company, will depart the Board effective April 20, 2026, due to Nippon's routine personnel rotations, with no disagreements on company matters. Under the December 9, 2024 Stockholder’s Agreement, Nippon retains the right to designate three directors as of March 16, 2026, including sitting directors Keith Gubbay and Tomohiro Yao, and plans to name a replacement for Kimura. The Company will appoint the replacement pending Board review for fiduciary compliance.
- ·Nippon's director designation right under Stockholder’s Agreement applies until its share ownership falls below 5%
- ·Departure notification received on March 11, 2026
- ·Event reported and filing dated March 16, 2026
16-03-2026
On March 12, 2026, Deere & Company's Board approved one-time performance-based restricted stock unit (PSU) grants under the John Deere 2020 Equity and Incentive Plan to named executive officers John C. May ($25M target value), Ryan D. Campbell ($5M), and Deanna M. Kovar ($5M), with grants to be made on or about March 19, 2026. The PSUs are earned based on Shareholder Value Added (SVA) performance relative to annual targets over a five-year period from November 3, 2025, to October 27, 2030, with time-based vesting through October 27, 2030, designed to align with the company's Leap Ambitions and promote retention. No financial declines or flat metrics reported.
- ·SVA defined as operating profit less (average assets x cost of capital) for three equipment operations segments.
- ·Payout ranges from 0% (below 90% of SVA target) to 175% (at or above 125% of target) per performance year, averaged over five years.
- ·Forfeiture if employment terminates in first three years except for death/disability; prorated vesting thereafter under certain conditions.
16-03-2026
LB Pharmaceuticals Inc announced that Director Zachary Prensky notified the Board on March 13, 2026, of his intent to retire and not stand for reelection at the 2026 Annual Meeting, with his term ending at that meeting's conclusion. His departure is not due to any disagreement with the Company, and he will continue as a Board member and Nominating and Corporate Governance Committee member until then, providing consulting services thereafter. The Company entered into an Amendment No. 1 to the Transition Agreement effective June 3, 2026, allowing continued vesting of his unvested stock options.
- ·Original Transition, Separation, and Consulting Agreement dated November 26, 2024.
- ·Transition Agreement Amendment to be filed as exhibit to Form 10-K for FY ended December 31, 2025.
- ·Registrant is an emerging growth company.
- ·Common Stock: par value $0.0001 per share, trading symbol LBRX.
16-03-2026
Twenty One Capital, Inc. held its annual shareholder meeting on March 12, 2026, where all 304,842,759 shares of Class B common stock entitled to vote unanimously elected seven directors: Jack Mallers, Paolo Ardoino, Zachary Lyons, Bo Hines, Raphael Zagury, Jared Roscoe, and Vikas J. Parekh to serve until the next annual meeting. On the same date, pursuant to the Governance Agreement, the Tether Affiliate Group Directors (Paolo Ardoino, Zachary Lyons, Bo Hines, Raphael Zagury) and SoftBank Directors (Jared Roscoe, Vikas J. Parekh) submitted letters of resignation from the board and committees, effective immediately upon request by Tether or SoftBank, respectively. The filing was submitted on March 16, 2026.
- ·Company is an emerging growth company.
- ·Class A common stock trades on NYSE under symbol XXI with par value $0.01 per share.
- ·Principal executive offices at 111 Congress Avenue, Suite 500, Austin, Texas 78701.
16-03-2026
Ondas Inc. (Nasdaq: ONDS) completed its acquisition of Rotron Aerospace Ltd., a UK-based developer of advanced unmanned aerial systems, VTOL platforms, long-range aircraft, and aero-engine technologies on March 16, 2026. The deal expands Ondas Autonomous Systems' capabilities in long-endurance autonomous platforms for defense, security, and NATO programs, while establishing a UK industrial base and leveraging Rotron's relationships with the UK Ministry of Defence. Ondas will provide Rotron outlook on its earnings call on March 25, 2026.
- ·Earnings conference call scheduled for March 25, 2026 at 8:30 a.m. Eastern Time
- ·IR Contact: 888-657-2377, ir@ondas.com
- ·Media Contact: Escalate PR, ondas@escalatepr.com
16-03-2026
Planet Fitness, Inc. (NYSE: PLNT) appointed Harmit Singh, Chief Financial and Growth Officer of Levi Strauss & Co., to its Board of Directors effective March 16, 2026, expanding the board to 10 members. Singh brings over four decades of experience, including leading IPOs at Levi Strauss and Hyatt Hotels, and growth at Yum! Brands. As of December 31, 2025, Planet Fitness had approximately 20.8 million members across 2,896 clubs in multiple countries, with 90% franchise-owned.
- ·Planet Fitness founded in 1992 in Dover, NH.
- ·Clubs located in all 50 US states, DC, Puerto Rico, Canada, Panama, Mexico, Australia, and Spain.
16-03-2026
Helmerich & Payne, Inc. (NYSE: HP) announced executive leadership updates following Trey Adams’ appointment as President and CEO on March 4, 2026, including the retirement of SVP and CFO Kevin Vann effective June 30, 2026, and the appointment of Todd Scruggs as new SVP and CFO effective July 1, 2026. Vann will serve as a senior advisor through December 31, 2026, to ensure a smooth transition while the company advances KCA Deutag integration and strategic priorities. The changes highlight internal leadership strength and continuity amid de-leveraging and operational improvements.
- ·Scruggs joined H&P in 2024 after serving as Partner at Veriten, with prior roles enhancing treasury, FP&A, capital allocation, and portfolio optimization.
- ·Fleet totals 345 land rigs (203 US, 137 international) and 5 offshore platform rigs as of February 4, 2026.
16-03-2026
California Resources Corp (CRC) appointed Michael Helm, age 58, as Vice President – Finance and Controller and principal accounting officer effective March 16, 2026, succeeding Noelle Repetti who is retiring after more than 11 years of service with no disputes or disagreements. Mr. Helm, previously Vice President – Finance, Oil and Gas post the December 2025 merger with Berry Corporation, has extensive prior experience at CRC, Berry, Occidental Petroleum, and others. The company will enter an Indemnification Agreement with Mr. Helm.
- ·Merger with Berry Corporation closed in December 2025.
- ·Mr. Helm served as Berry’s Chief Accounting Officer since 2017 and CFO from January 2023 to January 2025.
- ·Mr. Helm was previously Vice President and Corporate Controller of CRC from 2014 to 2017.
- ·No family relationships or material interests for Mr. Helm under Item 404(a) of Regulation S-K.
16-03-2026
Intrepid Potash, Inc. announced the departure of Chief Financial Officer Matthew Preston effective March 11, 2026, not due to any disagreements, with a separation agreement dated March 16, 2026, providing a $1.3M cash lump sum payment for transition services and forfeiture of unvested equity. The Board appointed Cris Ingold, the Company's Chief Accounting Officer, as interim principal financial officer effective the same day, with additional compensation of $12,000 per month and a $50,000 one-time cash bonus. No financial performance metrics were reported.
- ·Matthew Preston joined Intrepid in 2008 and led during 2024 management transition.
- ·Cris Ingold, age 61, has served as Chief Accounting Officer since April 2024, Corporate Controller from November 2019 to April 2024, and with the Company since 2011.
- ·No family relationships or reportable transactions involving Cris Ingold.
16-03-2026
On March 16, 2026, Sarah Raiss, a director at RB Global, Inc., notified the company of her decision to retire from the Board of Directors upon completion of her current term and will not stand for re-election at the 2026 Annual Meeting of Shareholders, anticipated for April 30, 2026. Her retirement does not stem from any disagreement with the company's operations, policies, or practices. No other changes or financial impacts were reported.
- ·The report was signed by Ryan Welsh, VP Legal & Corporate Secretary, on March 16, 2026.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)